clopidogrel and thromboxanes

clopidogrel has been researched along with thromboxanes in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Lecompte, T	1
Bhatt, DL; Meadows, TA	1
Lanas, A; Nardulli, G	1
Lindhoff-Last, E; Mani, H	1
Bhavaraju, K; Gartner, TK; Georgakis, A; Jin, J; Kunapuli, SP; Nurden, A; Nurden, P; Tomiyama, Y	1
Sas, K; Sztriha, LK; Vadász, D; Vécsei, L	1
Barrs, VR; Griebsch, C; Hall, E	1
Karwatowska-Prokopczuk, E; Li, L; Tsimikas, S; Witztum, JL; Yang, J	1

Reviews

5 review(s) available for clopidogrel and thromboxanes

Article	Year
[Platelet inhibitors: old and new]. La Tunisie medicale, 2002, Volume: 80, Issue:8 Suppl Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine	2002
Clinical aspects of platelet inhibitors and thrombus formation. Circulation research, 2007, May-11, Volume: 100, Issue:9 Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine	2007
[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants]. Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Middle Aged; Misoprostol; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Thromboxanes; Ticlopidine	2009
[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel]. Pharmazie in unserer Zeit, 2009, Volume: 38, Issue:4 Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Phosphorylation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Thromboxanes; Ticlopidine	2009
Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part II: Potential causes and laboratory tests. Ideggyogyaszati szemle, 2013, Jan-30, Volume: 66, Issue:1-2 Topics: Age Factors; Aspirin; Biological Availability; Clopidogrel; Drug Administration Schedule; Drug Interactions; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Sex Factors; Signal Transduction; Thromboxanes; Ticlopidine	2013

Trials

2 trial(s) available for clopidogrel and thromboxanes

Article	Year
Antagonism of P2Y₁₂ reduces physiological thromboxane levels. Platelets, 2010, Volume: 21, Issue:8 Topics: Adenosine Diphosphate; Adolescent; Adult; Animals; Blood Platelets; Clopidogrel; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Pilot Projects; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thromboxanes; Ticlopidine; Young Adult	2010
On-treatment platelet reactivity through the thromboxane A Journal of thrombosis and thrombolysis, 2023, Volume: 56, Issue:2 Topics: Aspirin; Blood Platelets; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thromboxanes; Treatment Outcome	2023

Article

Year

Antagonism of P2Y₁₂ reduces physiological thromboxane levels.

Platelets, 2010, Volume: 21, Issue:8

Topics: Adenosine Diphosphate; Adolescent; Adult; Animals; Blood Platelets; Clopidogrel; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Pilot Projects; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thromboxanes; Ticlopidine; Young Adult

2010

On-treatment platelet reactivity through the thromboxane A

Journal of thrombosis and thrombolysis, 2023, Volume: 56, Issue:2

Topics: Aspirin; Blood Platelets; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thromboxanes; Treatment Outcome

2023

Other Studies

1 other study(ies) available for clopidogrel and thromboxanes

Article	Year
Effectiveness of aspirin vs. clopidogrel in dogs with immune mediated haemolytic anaemia evaluated by serial thromboelastography and platelet mapping. Veterinary journal (London, England : 1997), 2022, Volume: 287 Topics: Adenosine Diphosphate; Anemia, Hemolytic, Autoimmune; Animals; Aspirin; Blood Platelets; Clopidogrel; Dog Diseases; Dogs; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombelastography; Thromboxanes	2022

Article

Year

Effectiveness of aspirin vs. clopidogrel in dogs with immune mediated haemolytic anaemia evaluated by serial thromboelastography and platelet mapping.

Veterinary journal (London, England : 1997), 2022, Volume: 287

Topics: Adenosine Diphosphate; Anemia, Hemolytic, Autoimmune; Animals; Aspirin; Blood Platelets; Clopidogrel; Dog Diseases; Dogs; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombelastography; Thromboxanes

2022